E-MAIL: support@healthxploreindia.com
E-MAIL: healthxploreindia@gmail.com
The long-acting injectable lenacapavir is intended for HIV pre-exposure prophylaxis (PrEP), with initial supplies expected by the end of 2026.
imphoenix82
Under the agreement, AbbVie will receive exclusive worldwide rights to develop and commercialise Nxera’s EP4 agonist for inflammatory bowel disease.
imphoenix82
The directive marks an important regulatory development for the pharmaceutical industry, bringing greater focus on quality assurance, manufacturing practices and compliance across the supply chain.
imphoenix82
The launch follows a series of recent regulatory approvals secured by Lupin in the US.
imphoenix82
Lonza will acquire the business for a mid-triple-digit million-euro amount. The transaction is expected to close in mid-2027, subject to customary regulatory approvals and other closing conditions.
imphoenix82
Researchers identified a likely pathogenic variant in a foetus with nonimmune hydrops fetalis and skeletal abnormalities using whole-exome sequencing, highlighting the diagnostic value of genomic testing in complex prenatal cases.
imphoenix82
Under the agreement, Rockwell Medical will acquire Vantive’s hemodialysis concentrates, monitors, water treatment systems, related consumables and technical services business, as well as its manufacturing facility in Italy.
imphoenix82
Philips Oxygenate 5 delivers continuous oxygen flow of 0.5–5 L/min and features quieter operation, digital flow monitoring and user-replaceable filters.
imphoenix82
Policymakers, industry leaders and biopharma startups discuss regulatory reforms, funding and shared infrastructure to accelerate India’s bioeconomy growth.
imphoenix82
The Health Ministry proposes adding additional Inland Container Depots (ICDs), a Special Economic Zone (SEZ), and an international airport to the list of authorised import locations for drugs and medical devices and cosmetics.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
